Pälvimäki, E P <br/><br/>
Deramciclane, a putative anxiolytic drug, is a serotonin 5-HT2C receptor inverse agonist but fails to induce 5-HT2C receptor down-regulation.  [electronic resource] 

 -  Psychopharmacology  Mar 1998 
 - 99-104 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0033-3158 
<br/><br/><label>Standard No.: </label>10.1007/s002130050544  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Anti-Anxiety Agents--pharmacology<br/>Brain--drug effects<br/>Camphanes--pharmacology<br/>Clozapine--pharmacology<br/>Inositol Phosphates--metabolism<br/>Male<br/>Rats<br/>Rats, Sprague-Dawley<br/>Receptor, Serotonin, 5-HT2A<br/>Receptor, Serotonin, 5-HT2C<br/>Receptors, Serotonin--drug effects<br/>Serotonin Antagonists--pharmacology